| mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |
| mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
| mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.1 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.1 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.078 |
0.1 |
| mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.1 |
| mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.1 |
| mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.1 |